Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis.

Human tumor necrosis factor-alpha (TNF), a mononuclear phagocyte (MO)-derived peptide, is increasingly being recognized for its pleomorphic immunologic effects. A number of studies have demonstrated that LPS can induce TNF synthesis, but data examining the production and regulation of TNF in human MO populations are lacking. In this study, we present data demonstrating that alveolar macrophages (AMO) and peripheral blood monocytes (PBM) obtained from 10 normal volunteers display a significant difference in both the production of TNF and their susceptibility to TNF regulation by prostaglandin E2 (PGE2) and dexamethasone (Dex). Adherent populations of PBM and AMO were incubated for 18 h in the presence of either LPS (10 micrograms/ml) alone, PGE2 for 1 h prior to LPS challenge, Dex for 1 h prior to LPS challenge, or control media alone. Cell-free supernatants were examined for TNF bioactivity and cellular TNF mRNA was assessed via in situ hybridization and Northern blot analysis. PGE2 and Dex treatment of PBM suppressed LPS-induced TNF production by 78% and 72%, respectively, while AMO-TNF production was suppressed by only 22% and 33%. The accumulation of TNF mRNA in PBM was reduced 63% by PGE2 and 45% by Dex, as assessed by laser densitometry. Similar studies demonstrated that TNF mRNA accumulation in AMO was reduced 12% and 13% by PGE2 and Dex, respectively. A 1,000-fold increase in PGE2 levels was necessary to induce 50% suppression of the maximal response to AMO as compared to PBM. These data support the notion that human MO derived from different compartments or stages of differentiation exhibit differential responsiveness to immunomodulators.

[1]  R. Strieter,et al.  Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline , 1988 .

[2]  R. Crystal,et al.  Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes. , 1988, The American review of respiratory disease.

[3]  C. Sprung,et al.  High-dose corticosteroids in patients with the adult respiratory distress syndrome. , 1987, The New England journal of medicine.

[4]  J. Vilček,et al.  Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. , 1987, Journal of immunology.

[5]  P. Scheurich,et al.  Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. , 1987, Journal of immunology.

[6]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[7]  J. Larrick,et al.  Tumor necrosis factor production by human sarcoid alveolar macrophages. , 1986, The American journal of pathology.

[8]  P. Pekala,et al.  Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor--the primary regulatory role of the hormone in 3T3-L1 adipocytes. , 1986, Archives of biochemistry and biophysics.

[9]  T. Strom,et al.  Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. , 1986, Journal of immunology.

[10]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[11]  H. Ochs,et al.  An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. , 1986, Journal of immunology.

[12]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[13]  J. Larrick,et al.  Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. , 1986, Biochemical and biophysical research communications.

[14]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.

[15]  M. Vassar,et al.  Prostaglandin E1 and Survival in Patients with the Adult Respiratory Distress Syndrome: A Prospective Trial , 1986, Annals of surgery.

[16]  D. Stern,et al.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.

[17]  B. Aggarwal,et al.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. , 1985, Journal of immunology.

[18]  I. Dawid,et al.  Epidermal keratin gene expressed in embryos of Xenopus laevis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.

[20]  G. Gifford,et al.  Rabbit tumor necrosis factor: mechanism of action , 1981, Infection and immunity.

[21]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[22]  V. Ferrans,et al.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. , 1979, The American journal of pathology.

[23]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.